Allison W. Kurian offers insight on using multigene panel testing to discover breast and ovarian cancer risks that may have otherwise went undetected. Multigene panel sequencing detected ovarian ...

Please provide your email address to receive an email when new articles are posted on . A kidney disease panel for 382 genes yielded a high success rate and was effective in identifying monogenic ...

San Francisco, USA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The Pan-Genomic and Multi-Gene Panel Testing Market reached a valuation of US$ 8,907.34 million in 2024 and is projected to grow steadily over the ...

The U.S. Preventive Services Task Force has endorsed self-testing as a viable option for cervical cancer screening in an effort to make testing more accessible and reduce cancer rates nationwide. The ...

HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal ...

Panel testing for genetic variants linked to more cancers is cost-effective than just testing or BRCA1/2 mutations, says a clinical director for a women's health company. If caught early, the survival ...

Forty-six BrOv and 33 PDAC patients were enrolled, and 44 BrOv and 31 PDAC participants underwent genetic testing. Seven pathogenic variants were identified in six BrOv participants (13.6%), and three ...